Involvement of presynaptic 5-HT1A receptors in the low propensity of brexpiprazole to induce extrapyramidal side effects in rats
详细信息    查看全文
文摘
Brexpiprazole has low cataleptogenic activity due to balanced 5-HT1A/D2 activity. Dialysis proposes preferential brexpiprazole effect on presynaptic 5-HT1A receptors. Aripiprazole has low cataleptogenic activity, primarily driven by D2 agonism. 5-HT1A agonists reverse catalepsy by preferential effect on presynaptic receptors.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700